Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 12, 2014

Primary Completion Date

July 11, 2019

Study Completion Date

July 11, 2019

Conditions

Solid Tumors

Interventions

DRUG

Gemcitabine plus PM060184

Trial Locations (2)

New York

Madrid